HONOLULU (KHON2) — July is National Sarcoma Awareness Month, a time to recognize the signs of this rare type of cancer that affects about 17,000 people in the U.S. every year. Sarcoma is a cancer that ...
A systematic review finds that diagnostic discordance in bone and soft tissue sarcoma may reduce survival, supporting expert second opinions. STS is a rare cancer that originates as an abnormal growth ...
The phase 1/2 SAINT study is currently investigating intravenous trabectedin plus ipilimumab and nivolumab in the first line for advanced soft tissue sarcoma. The study investigators from City of Hope ...
Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional TARPSWG study. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results